SBC Medical Group Holdings has formed a capital and business alliance with Taiwan-based NeuroBrain Dynamics and will improve the profitability of 287 clinics. It has obtained preferential sales rights in Japan and South Korea and will establish a foundation for B2B expansion in Asia. The investment will be made for a minority stake, and the jointly developed solutions are scheduled to be rolled out in Japan and overseas.
SBC Medical Group Holdings entered into a capital and business alliance with Taiwan-based NeuroBrain Dynamics Inc. dated 13 November 2026 and invested in NBD. The aim of the alliance is to improve profitability per clinic by introducing together an AI that increases revenue by improving average spend per visit and retention rates across 287 clinics in Japan and overseas, and an AI that reduces costs by automating medical-record creation, staff scheduling and promotional-content production. SBC also obtained preferential sales rights for NBD products in Japan and South Korea, with the aim of creating a new revenue source by providing them to external medical institutions. The local solutions are also expected to form a foundation for B2B expansion in Asia.
The 6 AI solutions to be jointly developed under the alliance include improvements in average spend per visit and retention rates, automation of medical-record creation, automatic scheduling for doctors and nurses, automatic generation of promotional creative, security monitoring and use of a sovereign LLM platform. In particular, recommendation tools for concierges and recommendation functions linked to user histories are intended to naturally generate opportunities for visits and increase LTV. PoC evaluation is expected to begin and be completed during 2026, followed by a phased rollout.
In the future, the companies aim to expand the domestic network and establish a common foundation for B2B expansion in Asia. They plan to use NBD's capabilities and track record in expanding across Asia, leverage the preferential sales rights in Japan and South Korea, and build a system for providing the products to external medical institutions. SBC has indicated a policy of combining these efforts with its expansion capabilities, including in 7 Asian cities, to balance data utilization and security, centered on a sovereign LLM platform.